Radiotheranostics Market Size, Share and Trends Analysis 2026 to 2035

Report Id: 1499 Pages: 185 Last Updated: 08 January 2026 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Radiotheranostics Market-

Radiotheranostics Market By Radioisotope:

  • Technetium-99
  • Gallium-68
  • Iodine-131
  • Iodine-123
  • 18F
  • Y-90
  • Lutetium (Lu) 177
  • Copper (Cu) 67
  • Copper (Cu) 64
  • Others (18F with Y-90)

Radiotheranostics Market Segmentation Analysis

Radiotheranostics Market By Source

  • Nuclear Reactors
  • Cyclotrons

Radiotheranostics Market By Approach         

  • Targeted Therapeutic (Rx)
  • Companion Diagnostic (DX)

Radiotheranostics Market By Application: 

  • Oncology
    • Thyroid Cancer
    • Neuroendocrine Cancer
    • Hepatocellular Carcinoma
    • Multiple Myeloma
    • Lymphoma
    • Others
  • Non-Oncology
    • Joint Infections
    • Arthritis
    • Bone Pain
    • Others

Radiotheranostics Market By End User:

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

North America Radiotheranostics Market By Country, 

  • U.S.
  • Canada

Europe Radiotheranostics Market By Country, 

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Radiotheranostics Market By Country, 

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Radiotheranostics Market By Country, 

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Radiotheranostics Market By Country,

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Radiotheranostics Market Snapshot

Chapter 4. Global Radiotheranostics Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Radioisotope Estimates & Trend Analysis

5.1. by Radioisotope & Market Share, 2025 & 2035

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Radioisotope:

5.2.1. Technetium-99

5.2.2. Gallium-68

5.2.3. Iodine-131

5.2.4. Iodine-123

5.2.5. 18F

5.2.6. Y-90

5.2.7. Lutetium (Lu) 177

5.2.8. Copper (Cu) 67

5.2.9. Copper (Cu) 64

5.2.10. Others

Chapter 6. Market Segmentation 2: by Source Estimates & Trend Analysis

6.1. by Source & Market Share, 2025 & 2035

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Source:

6.2.1. Nuclear Reactors

6.2.2. Cyclotrons

Chapter 7. Market Segmentation 3: by Approach Estimates & Trend Analysis

7.1. by Approach & Market Share, 2025 & 2035

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Approach:

7.2.1. Targeted Therapeutic (Rx)

7.2.2. Companion Diagnostic (DX)

Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis

8.1. by Application & Market Share, 2025 & 2035

8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Application:

8.2.1. Oncology

8.2.1.1. Thyroid Cancer

8.2.1.2. Neuroendocrine Cancer

8.2.1.3. Hepatocellular Carcinoma

8.2.1.4. Multiple Myeloma

8.2.1.5. Lymphoma

8.2.1.6. Others

8.2.2. Non-Oncology

8.2.2.1. Joint Infections

8.2.2.2. Arthritis

8.2.2.3. Bone Pain

8.2.2.4. Others

Chapter 9. Market Segmentation 5: by End-user Estimates & Trend Analysis

9.1. by End-user & Market Share, 2025 & 2035

9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by End-user:

9.2.1. Hospitals & Clinics

9.2.2. Pharmaceutical & Biotechnology Companies

9.2.3. Others

Chapter 10. Radiotheranostics Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Radiotheranostics Market Revenue (US$ Billion) Estimates and Forecasts by Radioisotope, 2022 - 2035

10.1.2. North America Radiotheranostics Market Revenue (US$ Billion) Estimates and Forecasts by Source, 2022 - 2035

10.1.3. North America Radiotheranostics Market revenue (US$ Billion) by Approach, 2022 - 2035

10.1.4. North America Radiotheranostics Market revenue (US$ Billion) by Application, 2022 - 2035

10.1.5. North America Radiotheranostics Market revenue (US$ Billion) by End-user, 2022 - 2035

10.1.6. North America Radiotheranostics Market Revenue (US$ Billion) Estimates and Forecasts by country, 2022 - 2035

10.2. Europe

10.2.1. Europe Radiotheranostics Market revenue (US$ Billion) by Radioisotope, 2022 - 2035

10.2.2. Europe Radiotheranostics Market revenue (US$ Billion) by Source, 2022 - 2035

10.2.3. Europe Radiotheranostics Market revenue (US$ Billion) by Approach, 2022 - 2035

10.2.4. Europe Radiotheranostics Market revenue (US$ Billion) by Application, 2022 - 2035

10.2.5. Europe Radiotheranostics Market revenue (US$ Billion) by End-user, 2022 - 2035

10.2.6. Europe Radiotheranostics Market revenue (US$ Billion) by country, 2022 - 2035

10.3. Asia Pacific

10.3.1. Asia Pacific Radiotheranostics Market revenue (US$ Billion) by Radioisotope, 2022 - 2035

10.3.2. Asia Pacific Radiotheranostics Market revenue (US$ Billion) by Source, 2022 - 2035

10.3.3. Asia-Pacific Radiotheranostics Market revenue (US$ Billion) by Approach, 2022 - 2035

10.3.4. Asia Pacific Radiotheranostics Market revenue (US$ Billion) by Application, 2022 - 2035

10.3.5. Asia Pacific Radiotheranostics Market revenue (US$ Billion) by End-user, 2022 - 2035

10.3.6. Asia Pacific Radiotheranostics Market revenue (US$ Billion) by country, 2022 - 2035

10.4. Latin America

10.4.1. Latin America Radiotheranostics Market revenue (US$ Billion) by Radioisotope, 2022 - 2035

10.4.2. Latin America Radiotheranostics Market revenue (US$ Billion) by Source, 2022 - 2035

10.4.3. Latin America Radiotheranostics Market revenue (US$ Billion) by Approach, 2022 - 2035

10.4.4. Latin America Radiotheranostics Market revenue (US$ Billion) by Application, 2022 - 2035

10.4.5. Latin America Radiotheranostics Market revenue (US$ Billion) by End-user, 2022 - 2035

10.4.6. Latin America Radiotheranostics Market revenue (US$ Billion) by country, 2022 - 2035

10.5. Middle East & Africa

10.5.1. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by Radioisotope, 2022 - 2035

10.5.2. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by Source, 2022 - 2035

10.5.3. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by Approach, 2022 - 2035

10.5.4. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by Application, 2022 - 2035

10.5.5. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by End-user, 2022 - 2035

10.5.6. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by country, 2022 - 2035

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances

11.2. Company Profiles

11.2.1. Novartis AG
11.2.2. Telix Pharmaceuticals
11.2.3. Curium
11.2.4. ITM Isotope Technologies
11.2.5. Eli Lilly (via POINT Biopharma)
11.2.6. AstraZeneca (via Fusion Pharmaceuticals)
11.2.7. Radiopharm Theranostics
11.2.8. Advanced Accelerator Applications (AAA)
11.2.9. Ratio Therapeutics
11.2.10. Radionetics Oncology

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
1108
Security Code field cannot be blank!

Frequently Asked Questions

Radiotheranostics Market Size is valued at USD 2.61 billion in 2025 and is predicted to reach USD 5.05 billion by the year 2035.

Radiotheranostics Market expected to grow at a 7.2% CAGR during the forecast period for 2026-2035

Novartis AG, Bayer AG, Telix Pharmaceuticals, ITM Isotope Technologies, Eli Lilly (via POINT Biopharma), AstraZeneca (via Fusion Pharmaceuticals), Rad

Radiotheranostics market is segmented on the radioisotope, source, approach, applications and end users. Based on radioisotope, the market is segmented into technetium-99, gallium-68, iodine-131, iodine-123, 18F, y-90, lutetium (lu) 177, copper (Cu) 67, copper (Cu) 64,.

North American region is leading the the Radiotheranostics Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying